Novan to Report Full Year 2021 Financial Results on February 22, 2022
DURHAM, N.C., Feb. 15, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
News
Sunshine Biopharma, Inc. Announces Pricing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market
MONTREAL, Feb. 15, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the…
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
Conference Call on Tuesday, March 1, 2022 at 8:30 a.m. ET LEXINGTON, Mass., Feb. 15,…
Healthy Extracts New Clinical Study Demonstrates UBN RELIEF Naturally Alleviates Migraine Symptoms
Double-Blind, Peer-Reviewed Study Published in World Journal of Advanced Research and Reviews UBN RELIEF™ UBN…
Palisade Bio (NASDAQ: PALI) Adds Pharmaceutical Industry Executive Robert McRae to Leadership Team
Expands Clinical Operations Team in Advance of Pivotal Clinical Studies CARLSBAD, Calif., Feb. 15, 2022…
Monopar Announces Clinical and Preclinical Program Updates
Validive Phase 2b/3 VOICE trial now open at 43 sites; active and enrolling in US…
Propella Therapeutics Presents Non-Clinical Data on PRL-02 at 2022 ASCO Genitourinary (GU) Cancers Symposium
Highlights Potential of PRL-02 as Best-in-Class, Next-Generation Androgen Biosynthesis Inhibitor for Treatment of Advanced Prostate…
Zogenix Supports New No-Cost Genetic Testing Program with United Mitochondrial Disease Foundation to Improve Diagnosis of Mitochondrial Diseases
Symptoms of mitochondrial diseases, such as Thymidine Kinase 2 deficiency (TK2d), can vary widely and…
PDS Biotech Announces Clinical Trial with Mayo Clinic to Study PDS0101 in Early Stage Pre-Metastatic- HPV-Associated Head and Neck Cancer
The study evaluates PDS0101 with and without KEYTRUDA® prior to surgery for HPV-associated oropharyngeal cancer…
Hepion Pharmaceuticals Appoints World-Renowned Hepatologist, Dr. Eddie C. Cheung, to Lead the Company’s Strategic Medical Affairs in Asia
– Dr. Cheung, who has dedicated his career to NASH, hepatocellular carcinoma, fatty liver disease,…
Stella Diagnostics CEO Discusses Competitive Advantage in Early Cancer Detection During Audio Interview with SmallCapVoice.com
SmallCapVoice.com Interview with Stella Diagnostics Inc. SmallCapVoice.com Inc. (“SCV”) announces the availability of a new…
Portage Biotech Announces New Appointments to its Management Team and Board of Directors
Leading biopharma executive Brian Wiley joins as Chief Business Officer Experienced financial consultant Joseph Ciaverella…
Amarin to Report Fourth Quarter and Full Year 2021 Financial Results And Host Conference Call on March 1, 2022
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 15, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
Cue Biopharma’s Therapeutic Immuno-STAT Biologics to be Featured in Oxford University Presentation at the Biophysical Society 2022 Annual Meeting
Presentation provides mechanistic insights and progress update on collaboration with the laboratory of Michael Dustin…
Marrone Bio and Corteva Agriscience Announce New Distribution Contract
The companies build on existing seed treatment partnership to offer novel foliar bionutrient GENEVA and…
InMed Pharmaceuticals Strengthens its Commercial Leadership Team with the Appointment of Vice President of Sales and Marketing for BayMedica
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Intellia and ONK Therapeutics Announce Collaboration to Advance Allogeneic CRISPR-Edited NK Cell Therapies for the Treatment of Patients with Cancer
Collaboration combines Intellia’s genome editing platform with ONK’s optimized natural killer (NK) cell therapy platform…
Mustang Bio Announces City of Hope MB-105 Prostate Stem Cell Antigen CAR T Data Selected for Presentation at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium
WORCESTER, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
Repligen Launches AAV Affinity Resins for Gene Therapy Purification
AVIPure® affinity resins address the market need for high performance and caustic stability WALTHAM, Mass.,…